| IBKR |
Report |
GAAP diluted EPS |
BEAT |
pred ~$0.66 vs. cons $0.61 |
HIGH |
| IBKR |
Report |
Total net revenues |
BEAT |
pred ~$1.78B vs. cons $1.66B |
HIGH |
| IBKR |
Report |
Net interest income |
BEAT |
pred ~$980M vs. cons $930M |
MEDIUM |
| IBKR |
Guide |
FY2026 EPS run-rate implied by H1 trend |
BETTER |
guide ~$2.60 vs. cons $2.46 (FY2026) |
MEDIUM |
| IBKR |
Guide |
Q2 pretax margin (seasonal comp step-up) |
LOWER |
guide ~74% vs. cons/prior-quarter run-rate 77% (Q2 2026) |
MEDIUM |
| IBKR |
Guide |
NII rate-sensitivity disclosure (25bp USD cut impact) |
UNCHANGED |
guide ~$80M annualized hit vs. prior guide $80M (forward-looking, per 25bp cut) |
LOW |
| IBKR |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.0% |
— |
MEDIUM |
| IBKR |
Return |
5-day cumulative residual |
+0.6% (FADE) |
Monthly DARTs/margin-loan disclosures already pre-telegraphed most of the top-line beat, so the initial pop should be muted rather than explosive; with shares up ~69% over the past year and trading near all-time highs into the print, any softness in Q2 pretax margin (seasonal comp/FICA step-up from 77% in Q1) or measured commentary on marketing spend/cash-yield competition could prompt profit-taking over the week even as full-year EPS estimates get revised modestly higher, pulling the initial idiosyncratic gain back toward flat by day 5. |
LOW |